Overdue ACMD Report Gets New Deadline as Industry Weighs In
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics.
Written by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to patients in the UK, following what is believed to be the first time a coroner has found that a prescription for cannabis contributed to a death in the country.
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in 2018.
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products.
Last week, the UK’s Advisory Council on the Misuse of Drugs published an official recommendation that the THC limit on industrial hemp should be raised to 0.3%, bringing it in line with the EU.
As reported by Cannabis Health. The government has accepted recommendations for permitted levels of controlled cannabinoids in CBD products, in a step towards establishing the first legal framework for the industry.
A report from the government’s Advisory Council on the Misuse of Drugs (ACMD) that recommended the decriminalisation of drugs will remain the only one in the council’s history not to be released to the public.
LAST week saw the British Government reinstate its hardline position on drug policy, as Policing Minister Kit Malthouse announced new headline-grabbing policies aimed at cracking down on football fans and ‘middle class’ drug users.